Learn More
Medchemexpress LLC T025 | 2407433-00-3 | 99.6% | 382.42 | 10 MG

Supplier: Medchemexpress LLC HY11229610MG
T025 is an orally active and highly potent inhibitor of Cdc2-like kinase (CLKs). It induces caspase-3/7-mediated cell apoptosis, reduces CLK-dependent phosphorylation, and exhibits anti-proliferative activities in hematological and solid cancer cell lines. T025 primarily has anti-tumor efficiency for MYC-driven disease research.
- Orally active and highly potent inhibitor of Cdc2-like kinase (CLKs)
- Induces caspase-3/7-mediated cell apoptosis
- Reduces CLK-dependent phosphorylation
- Exhibits anti-proliferative activities in hematological and solid cancer cell lines
- Anti-tumor efficiency for MYC-driven disease research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.